• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #ScientificSessions26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 8th, 2026

Thank you to our sponsors and supporters


Bold white 'THANK YOU!' text on red background with radiating lines

The American Heart Association is grateful for the continued support and generosity of our exhibitors and sponsors. We want to recognize the following companies for their support of additional sponsorship and advertising opportunities.

  • Alnylam Pharmaceuticals, Inc.
  • Amgen Inc.
  • Ann & Robert Lurie Children’s Hospital of Chicago
  • Answers in CME
  • Arrowhead Pharmaceuticals, Inc.
  • AskBio Inc.
  • AstraZenca
  • Bayer
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • BridgeBio Pharma, Inc.
  • Bristol Myers Squibb
  • Bristol Myers Squibb | Johnson & Johnson
  • Caristo Diagnostics
  • Cedar Sinai Hospital
  • Cleerly, Inc
  • Corcept Therapeutics Inc
  • Cytokinetics, Inc.
  • Decera Clinical
  • Edwards Lifesciences LLC
  • Eli Lilly & Company
  • Esperion Therapeutics, Inc.
  • Haymarket Medical Education
  • (Heart) Cardiovascular-Kidney-Metabolic Syndrome (CKMH)
  • (Heart) Quality, Outcomes, Research & Analytics
  • (Heart) Target: Aortic Stenosis | Quality & Health IT
  • Heartflow, Inc.
  • Idorsia Pharmaceuticals USA
  • Intellia Therapeutics, Inc.
  • Ionis Pharmaceuticals Inc.
  • Kiniksa Pharmaceuticals Corporation
  • Lexeo Therapeutics, Inc.
  • LIB Therapeutics
  • Medscape Live Meeting Services
  • Medtronic, Inc.
  • Merck & Co., Inc.
  • Milestone Pharmaceuticals, Inc
  • Mineralys Therapeutics
  • New Amsterdam Pharma
  • Novartis Pharmaceutical Corporation
  • Novo Nordisk, Inc.
  • PeerView Operation Services America LLC
  • Pfizer Inc.
  • Prime Education
  • Vindico Medical Education
  • Wolters Kluwer

Educational Grant Support Provided by:

  • AstraZeneca Pharmaceuticals
  • Alnylam U.S., Inc.
  • DexCom, Inc.
  • Novartis Pharmaceutical Corporation
  • Chiesi USA, Inc.
  • Biosence Webster, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • J&J MedTech, Heart Recovery
  • Impulse Dynamics
  • Stryker Corporation
Interesting Stories
Latest research on thromboembolic disease targets
Sponsored by BMS/J&J Alliance
Latest research on thromboembolic disease targets
Prompt referral can be lifesaving
Sponsored by Edwards Lifesciences
Prompt referral can be lifesaving
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
Sponsored by Novo Nordisk Inc.
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
Join us at the TRYNGOLZA® (olezarsen) Expert Theater at Scientific Sessions
Sponsored by Ionis Pharmaceuticals
Join us at the TRYNGOLZA® (olezarsen) Expert Theater at Scientific Sessions
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Sponsored by Novartis Pharmaceuticals Corporation
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Severe hypertriglyceridemia: see the data at Scientific Sessions, Booth #2802
Sponsored by Ionis Pharmaceuticals
Severe hypertriglyceridemia: see the data at Scientific Sessions, Booth #2802
More Content
Dr. Manesh Patel presenting at a medical conference with a world map showing global death statistics by ACAD per 100,000 in 2021
Daily Coverage
Patel: Solving science’s ‘last-mile problem’
Nov 8th, 2026
Scientific Sessions conference stage with red branding, large display screens, and audience seated in auditorium
Late-Breaking Science
Reports find multiple approaches improve outcomes after stroke
Nov 8th, 2026
Scientific Sessions conference stage with red branding, multiple screens displaying presentations, and audience seating
Late-Breaking Science
Late-breaking trials challenge conventional treatments to cardiovascular disease
Nov 8th, 2026
Medical conference speaker Eric J. Topol presenting on cardiovascular research with Nature Medicine branding on display screens
Daily Coverage
Keynote speaker: Missed opportunities could lead to great discoveries
Nov 7th, 2026
Large auditorium filled with attendees at a corporate conference or convention event with stage and screens
Late-Breaking Science
Lessons from landmark trials
Nov 7th, 2026
Professional man speaking at podium wearing glasses and business attire during presentation event
Daily Coverage
Nobel Laureate: Outcomes at the end of the road not taken
Nov 7th, 2026
Business professionals networking at conference booth with exhibition signage in background
Daily Coverage
Putting clinical skills to the test
Nov 7th, 2026
Professional headshot of a smiling woman with white hair wearing a black shirt against a gray background
Daily Coverage
The hidden risks after Pulmonary Embolism
Nov 7th, 2026
Professional headshot of a smiling man in a dark blue shirt against an office background
Daily Coverage
Using mRNA to treat cardiovascular disease
Nov 7th, 2026
Professional headshot of a woman with black wavy hair, glasses, and burgundy top smiling against dark background
Daily Coverage
Connecting the dots in cardio-kidney-metabolic
Nov 7th, 2026
Professional headshot of a woman with long brown hair, red lipstick, wearing a dark blazer and pearl necklace against a gray background
Daily Coverage
Cardiac CT offers a clearer picture of CVD
Nov 7th, 2026
Professional headshot of a smiling man wearing glasses and light blue shirt with burgundy tie against red and white striped background
Daily Coverage
CRISPR revolution nears mainstream cardiovascular care
Nov 6th, 2026